The impact of the 21-gene assay in the Czech Republic on adjuvant chemotherapy (CT) recommendations and costs in estrogen receptor positive (ER+) early stage breast cancer (ESBC) patients with grade 2 tumors and risk factors

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 27; p. vi53
Main Authors Petrakova, K., Petruzelka, L., Holanek, M., Svoboda, T., Palacova, M., Bielcikova, Z., Zbozinkova, Z.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2016
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdw364.33